|
|
|
Volumn 132, Issue 50, 1997, Pages 1903-1904
|
|
Registration procedure in the Netherlands continues: Glaxo Wellcome discontinues the sale of a promising antidiabetic agent;GLAXO WELLCOME STAAKT VERKOOP VEELBELOVEND ANTIDIABETICUM
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
TROGLITAZONE;
DRUG MARKETING;
HUMAN;
LIVER TOXICITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
|
|
EID: 0030828741
PISSN: 00316911
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|